What did Fisher & Paykel Healthcare Corporation Limited announce?

Fisher & Paykel Healthcare Corporation Limited (NZX: FPH) filed “Capital Change Notice - Issue of Employee Share Rights” with NZX on 9 September 2026, as a capital change announcement.

When was it filed?
9 September 2026
Where is the original?
NZX announcement
Fisher & Paykel Healthcare Corporation Limited logo

Capital Change Notice - Issue of Employee Share Rights

Capital Change9 September 2026FPHHealthcare

Capital Change Notice



9 September 2026

Issue of Employee Share Rights

This notice is given under NZX Listing Rule 3.13.1 and relates to unlisted Employee Share Rights to acquire

ordinary shares in the Company (‘ESRs’) issued under the Fisher & Paykel Healthcare Employee Share

Rights Plan (‘Employee Share Rights Plan’), the Sub-Plan for France (‘Sub-Plan for France’) and the Fisher

& Paykel Healthcare Employee Share Rights Plan – North America (‘North America Plan’).


Section 1: Issuer information

Name of issuer

Fisher & Paykel Healthcare

Corporation Limited

NZX ticker code FPH

Class of financial product Unlisted ESRs to acquire ordinary

shares in the Company issued

under the Employee Share Rights

Plan, the Sub-Plan for France and

the North America Plan.

ISIN (If unknown, check on NZX website) NZFAPE0001S2

Currency NZD

Section 2: Capital change details

Number issued/acquired/redeemed 299,018

Nominal value (if any) Not applicable

Issue/acquisition/redemption price per security

No amount is payable for the grant

of ESRs. One ESR will convert

into one ordinary share at no cost

after three years, provided the

recipient remains an employee of

the Company.

Nature of the payment (for example, cash or other consideration) Not applicable

Amount paid up (if not in full) Not applicable

Percentage of total class of Financial Products

issued/acquired/redeemed/ (calculated on the number of Financial

Products of the Class, excluding any Treasury Stock, in existence)

1


299,018 ESRs to acquire ordinary

shares representing approximately

0.0508% of the ordinary shares on

issue.

For an issue of Convertible Financial Products or Options, the

principal terms of Conversion (for example the Conversion price and

Conversion date and the ranking of the Financial Product in relation

to other Classes of Financial Product) or the Option (for example,

the exercise price and exercise date)

Not applicable

Reason for issue/acquisition/redemption and specific authority for

issue/acquisition/redemption/ (the reason for change must be

identified here)

Issue of ESRs under the

Employee Share Rights Plan to

incentivise selected employees to

grow the Company and to attract,

motivate and retain key

employees.

Total number of Financial Products of the Class after the

issue/acquisition/redemption/Conversion (excluding Treasury Stock)

and the total number of Financial Products of the Class held as

Treasury Stock after the issue/acquisition/redemption.

Total number of ESRs on issue as

at the date of this notice after the

issue disclosed in this notice:

886,792


1

The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.


In the case of an acquisition of shares, whether those shares are to

be held as treasury stock

Not applicable

Specific authority for the issue, acquisition, or redemption, including

a reference to the rule pursuant to which the issue, acquisition, or

redemption is made

Directors’ resolution dated 25

August 2026.

Terms or details of the issue, acquisition, or redemption (for

example: restrictions, escrow arrangements)

The ESRs will be issued on the

terms of the Employee Share

Rights Plan, the Sub-Plan for

France and the North America

Plan, as approved by the Board.

Date of issue/acquisition/redemption

2

8 September 2026

Section 3: Authority for this announcement and contact person

Name of person


authorised to make this announcement Raelene Leonard

Contact person for this announcement Raelene Leonard

Contact phone number +64 9 610 4803

Contact email address Raelene.Leonard@fphcare.co.nz

Date of release through MAP


9 September 2026


























2

Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant issue/acquisition/redemptions were

made (for example, 1 January 2019 to 31 January 2019).

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • EBO — EBOS Group Limited: Capital Change Notice - Employee Share Plan
    2026-09-16

    “Capital Change Notice Section 1: Issuer information Name of issuer EBOS Group Limited NZX ticker code EBO Class of financial product Ordinary Shares ISIN (If unknown, check on NZX website) NZEBOE0001S6 Currency NZD Section 2: Capital change details Number issued/acq…”

  • GNE — Genesis Energy Limited: Capital Change Notice - Issue of Additional Share Rights
    2026-07-01

    “Capital Change Notice • 3,307 RSRs have a vesting date of 30 June 2029). The balance of the principal conversion terms is set out in a Capital Change Notice lodged with NZX MAP on 1/08/2025. Reason for issue/acquisition/redemption and specific authority for issue/acq…”

  • MCY — Mercury NZ Limited: Capital Change Notice
    2026-08-27

    “Capital Change Notice Section 1: Issuer information Name of issuer Mercury NZ Limited (Mercury) NZX ticker code MCY Class of financial product Unquoted Performance Share Rights (PSRs), convertible to Mercury NZ Limited ordinary shares pursuant to Mercury NZ Limited – Sha…”